Assessing the tolerability and toxicity of Levatinib plus Pembrolizumab for recurrent endometrial cancer: A real world experience (1110)

Autor: Becker, Mariel, Buchanan, Tommy, Burton, Elizabeth, Edelson, Mitchell, Sorosky, Joel, Shahin, Mark
Zdroj: In Gynecologic Oncology September 2023 176 Supplement 1:S84-S84
Databáze: ScienceDirect